XOMA Royalty Corporation (XOMA)
Free
No email, no account, no signup.
Pulling latest news for XOMA Royalty Corporation…
Bull
Bear
Want the why behind the signal? Get the deep 4-model report — full bull/bear, dated catalysts, dilution risk, weekly refresh. $4.99.
Get the deep 4-model report – $4.99
Order analysis – $4.99
Not satisfied? Get your money back within 7 days — no questions asked.
7-day money-back guarantee · No lock-in period · Secure payment via Stripe
Exchange
NASDAQ
Type
Royalty Company
Sector
Biotech royalty aggregator
Market Cap
$501M
We're already tracking XOMA Royalty Corporation — here are the latest events we've registered
Recent News
- On April 27, 2026, Ligand Pharmaceuticals announced an agreement to acquire XOMA Royalty for approximately $739 million. Stockholders will receive $39.00 per share in cash and a contingent value right (CVR) for 75% of net proceeds from certain pending litigation. The acquisition is expected to close in the third quarter of 2026.
Want to know how this news affects XOMA Royalty Corporation? Order the analysis.
Order analysis – $4.99
What you get
A complete express analysis — not just a signal. Delivered as a webpage in your account.
- Signal: BUY / HOLD / SELL — with clear reasoning
- Sentiment score 1–10 based on news, reports, and market data
- Risk score 1–10 (dilution, jurisdiction, execution)
- Bull case: 3–5 specific points with evidence (e.g. "Oversold after panic-reaction to security news, opening a technical bounce setup")
- Bear case: 3–5 specific risks (e.g. "Extreme uncertainty around the security situation in Sinaloa after tragic events")
- Upcoming catalysts with dates
- Assessment of dilution risk
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of XOMA Royalty Corporation will be delivered in the same format.
Not satisfied? Get your money back within 7 days — no questions asked.
The information on this page does not constitute investment advice. AI-generated analyses may contain errors. Always conduct your own research before making investment decisions. Firelda.ai is not responsible for any potential losses.